Literature DB >> 7731920

Use of enzyme-linked immunosorbent assay and enzyme-linked immunoelectrotransfer blot for the diagnosis and monitoring of neurocysticercosis.

C Simac1, P Michel, A Andriantsimahavandy, P Esterre, A Michault.   

Abstract

A total of 70 proven cases of neurocysticercosis from la Réunion (Indian Ocean) were studied with enzyme-linked immunoassay (ELISA) and immunoelectrotransfer blot (EITB) to detect specific antibodies in serum and cerebrospinal fluid (CSF). Absorbance levels of antibody to crude Taenia solium cyst extract as an antigen were compared with EITB banding-pattern and computed tomography-scan results. The EITB analysis of sera and CSF from patients with active neurocysticercosis, confirmed with characteristic brain-scan imaging and highest ELISA absorbance, regularly revealed two bands with molecular weights of 13 and 14 kDa, respectively. These low-molecular-weight fractions are potential markers of active cerebral cysticercosis, a result obtained in the simple epidemiological situation of La Réunion (Indian Ocean). A parallel study is underway in Madagascar, where cross-reactivities with other parasitic diseases, including Schistosoma infections, may interfere.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731920     DOI: 10.1007/bf00931618

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  24 in total

1.  Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG).

Authors:  J F Diaz; M Verastegui; R H Gilman; V C Tsang; J B Pilcher; C Gallo; H H Garcia; P Torres; T Montenegro; E Miranda
Journal:  Am J Trop Med Hyg       Date:  1992-05       Impact factor: 2.345

2.  Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 1. Radiological, physiological and histopathological studies.

Authors:  A Flisser; D Gonzalez; M Shkurovich; I Madrazo; D Correa; J Rodriguez-Carbajal; S Cohen; E Rodriguez-del-Rosal; M Collado; B Fernandez
Journal:  Parasitol Res       Date:  1990       Impact factor: 2.289

3.  Demonstration of species-specific and cross-reactive components of Taenia solium metacestode antigens.

Authors:  B Gottstein; V C Tsang; P M Schantz
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

4.  Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru.

Authors:  H H Garcia; M Martinez; R Gilman; G Herrera; V C Tsang; J B Pilcher; F Diaz; M Verastegui; C Gallo; M Porras
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

5.  The relationship of antibody levels to the clinical spectrum of human neurocysticercosis.

Authors:  D Zini; V J Farrell; A A Wadee
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

6.  Cross reactions in the immunodiagnosis of schistosomiasis and cysticercosis by a cerebrospinal fluid enzyme-linked immunosorbent assay.

Authors:  M D Pammenter; S R Epstein; R T Rees
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Jan-Feb       Impact factor: 2.184

7.  Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel.

Authors:  B Estañol; H Juárez; M del C Irigoyen; D González-Barranco; T Corona
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  [Diagnosis of cerebral cysticercosis on Réunion Island by an immuno-enzymological method (ELISA): comparison with x-ray computed tomography].

Authors:  A Michault; P Coubes; J P Laporte; E Bouillan-Linet; D Leroy
Journal:  Pathol Biol (Paris)       Date:  1988-03

9.  Albendazole therapy for neurocysticercosis.

Authors:  F Escobedo; P Penagos; J Rodriguez; J Sotelo
Journal:  Arch Intern Med       Date:  1987-04

10.  [Epidemiology of cysticercosis in Madagascar].

Authors:  P Michel; P Callies; H Raharison; P Guyon; L Holvoet; C Genin
Journal:  Bull Soc Pathol Exot       Date:  1993
View more
  8 in total

1.  Serological diagnosis of human cysticercosis by use of recombinant antigens from Taenia solium cysticerci.

Authors:  K Hubert; A Andriantsimahavandy; A Michault; M Frosch; F A Mühlschlegel
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

2.  Humoral immune response in chromoblastomycosis during and after therapy.

Authors:  P Esterre; M Jahevitra; A Andriantsimahavandy
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

3.  Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis.

Authors:  A X Pardini; A J Vaz; L Dos Ramos Machado; J A Livramento
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

4.  Use of Taenia crassiceps cysticercus antigen preparations for detection of antibodies in cerebrospinal fluid samples from patients with neurocysticercosis (Taenia solium).

Authors:  Alessandra Xavier Pardini; Regina Helena Peralta; Adelaide José Vaz; Luis dos Ramos Machado; José Mauro Peralta
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

5.  Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid.

Authors:  Lorraine Michelet; Agnès Fleury; Edda Sciutto; Eric Kendjo; Gladis Fragoso; Luc Paris; Bernard Bouteille
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

6.  A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches.

Authors:  Joachim Blocher; Erich Schmutzhard; Patricia P Wilkins; Paige N Gupton; Matthias Schaffert; Herbert Auer; Thaddaeus Gotwald; William Matuja; Andrea S Winkler
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

7.  Evaluation of an immunodot blot technique for the detection of antibodies against Taenia solium larval antigens.

Authors:  Fernando Salazar-Anton; Aleyda Tellez; Johan Lindh
Journal:  Parasitol Res       Date:  2012-01-04       Impact factor: 2.289

8.  Further characterization of Tsol-p27 as a diagnostic antigen in sub-Saharan Africa.

Authors:  Noémia Nhancupe; Fernando Salazar-Anton; Emília Virginia Noormahomed; Sónia Afonso; Johan Lindh
Journal:  Exp Parasitol       Date:  2013-09-13       Impact factor: 2.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.